Loading page...
Loading page...
A complete guide to Technology Readiness Levels (TRL 1–9) as used in Horizon Europe, EIC Accelerator, and EIC Pathfinder — with concrete examples, assessment criteria, and which EU programmes fund each TRL range.
Pick the statement closest to where your technology is today. It opens right here with everything about that level: what it means, what evaluators expect, how to reach the next one, and who funds it.
Someone has observed a scientific effect that could one day become a technology. There is no product idea yet, only a principle backed by research. Most work at this level happens in universities and research labs.
“TRL 1: Basic principles observed”
Horizon Europe Work Programme 2023-2025, General Annexes ↗A new mathematical or algorithmic result published in a paper, with no implementation beyond a sketch.
A material or physical effect observed in experiments, such as an unusual conductivity, before anyone has tried to use it.
A biological mechanism or target identified in basic research, for example a protein linked to a disease.
A chemical reaction or physical effect that could store or convert energy, seen in the lab for the first time.
EIC Pathfinder funds early research that ends at TRL 4 at most, so these projects started at TRL 1 to 3.
You know what you would build and what it would be used for, but it exists on paper, in models or in simulations. The application is still speculative: nothing has been tested experimentally.
“TRL 2: Technology concept formulated”
Horizon Europe Work Programme 2023-2025, General Annexes ↗An architecture and data-flow design for a new system, maybe with simulations, but no working prototype.
Device designs and models showing how the effect could be used in a sensor, chip or machine.
A therapeutic or diagnostic concept built on a known target, supported by literature and modelling.
A conceptual design for a new cell, reactor or process, backed by calculations and simulations.
EIC Pathfinder funds early research that ends at TRL 4 at most, so these projects started at TRL 1 to 3.
Experiments, not just theory, show that the core idea works. The separate pieces are not yet integrated into one system, but the critical function has been demonstrated in the lab.
“TRL 3: Experimental proof of concept”
Horizon Europe Work Programme 2023-2025, General Annexes ↗A working algorithm or model shown to perform the key task on sample data, outside any real product.
Individual components tested on the bench, proving the key effect works as predicted.
In vitro results showing the candidate acts on the target as expected.
A lab-scale cell or reactor produces the expected effect, with measured performance.
EIC Pathfinder funds early research that ends at TRL 4 at most, so these projects started at TRL 1 to 3.
The components now work together as a basic prototype, often called a breadboard, in a controlled lab setting. It does the intended job, but it looks nothing like the final product and has not faced real-world conditions.
“TRL 4: Technology validated in a lab”
Horizon Europe Work Programme 2023-2025, General Annexes ↗An integrated prototype running end to end on test data in a development environment.
A breadboard prototype with the main components connected and performing the intended function.
Integrated lab validation, such as early preclinical studies or a diagnostic tested on lab samples.
A single cell or small stack assembled and tested in the lab against target performance.
EIC Transition takes lab-validated results (around TRL 3 to 4) towards TRL 5 to 6, so these projects passed through this level.
The prototype has left the clean lab and been tested in conditions that resemble real use: realistic data, loads, temperatures or users. Fidelity is much higher. This is roughly where the EIC Accelerator expects you to be when you apply.
“TRL 5: Technology validated in a relevant environment (industrially relevant environment in the case of key enabling technologies)”
Horizon Europe Work Programme 2023-2025, General Annexes ↗A prototype tested with realistic data and a small group of pilot users in a staging environment.
A higher-fidelity prototype run on a test rig that simulates real operating conditions, such as heat or vibration.
Preclinical validation in models close to the human situation, or a diagnostic tested on real clinical samples.
A kilowatt-scale unit tested on a rig that reproduces real operating conditions.
EIC Transition takes lab-validated results (around TRL 3 to 4) towards TRL 5 to 6, so these projects passed through this level.
A prototype that closely represents the final system has been demonstrated, not just tested, in a relevant environment. It looks and behaves much like the real thing. Many deep-tech companies apply to the EIC Accelerator from here.
“TRL 6: Technology demonstrated in a relevant environment (industrially relevant environment in the case of key enabling technologies)”
Horizon Europe Work Programme 2023-2025, General Annexes ↗A beta product used by representative customers in a near-production environment.
An engineering model, close to final form, demonstrated under realistic conditions.
Commonly mapped to early clinical work, such as first-in-human (Phase 1) studies or a device's first clinical evaluation.
A pilot plant or pilot installation operating in a relevant setting.
The EIC Accelerator expects TRL 5 to 6 at application and funds development up to TRL 8, so these companies applied from about here.
A near-final prototype has run in the actual environment it was built for: a real factory, hospital, grid or customer site. This is a major step, because real-world conditions expose problems no test rig can.
“TRL 7: System prototype demonstration in an operational environment”
Horizon Europe Work Programme 2023-2025, General Annexes ↗A pilot deployment in production with real customers and real data.
A prototype operating on a real production line, vehicle or site.
Commonly mapped to later clinical trials (Phase 2) or a device clinical investigation.
A demonstration plant running at an operational site.
The EIC Accelerator funds companies from TRL 5 to 6 up to TRL 8, so these companies work through this level with EU support.
The final product exists and has passed the testing, qualification or certification it needs. It is ready for its first commercial deployments. The EIC Accelerator grant typically takes companies up to this point.
“TRL 8: System complete and qualified”
Horizon Europe Work Programme 2023-2025, General Annexes ↗A complete product with the security, compliance or certification it needs, such as ISO 27001 or a CE mark for medical software.
A qualified production unit that has passed the required certification tests.
Commonly mapped to pivotal trials (Phase 3) and regulatory approval, or a CE mark under the EU device rules.
A first-of-a-kind commercial unit, certified and connected.
The EIC Accelerator grant takes companies up to TRL 8 and its equity can follow them to market.
The technology is in its final form and running in real commercial or operational use. Grants rarely fund this stage; growth usually comes from revenue, equity investment or loans.
“TRL 9: Actual system proven in an operational environment (competitive manufacturing in the case of key enabling technologies, or in space)”
Horizon Europe Work Programme 2023-2025, General Annexes ↗A product sold and running at scale in customers' daily operations.
Units in service or manufactured competitively at volume.
A marketed product with post-market monitoring.
Commercial plants or a fleet operating and selling energy or services.
Evaluators assess the TRL of the specific innovation the grant will advance, not your company. Different parts of one system can sit at different levels.
Published
Technology Readiness Levels (TRL) are a 9-point scale developed by NASA in the 1970s and adopted by the European Commission as the standard framework for assessing how close a technology is to commercial deployment. Every Horizon Europe and EIC programme specifies eligible TRL ranges in its call text — applying at the wrong TRL is one of the most common reasons for instant rejection.
The TRL scale runs from TRL 1 (basic principles observed) to TRL 9 (technology proven in operational environment). Each level represents a distinct milestone in the journey from laboratory concept to market-ready product. The Commission uses TRL to match companies and research teams with the right funding instrument: early-stage research gets grants for exploration, mid-stage technologies get development funding, and near-market innovations get blended finance combining grants with equity.
Understanding TRL is not just a box-ticking exercise. Evaluators use your stated TRL as a credibility test. If you claim TRL 6 but cannot produce test data from a relevant environment, your proposal loses credibility on the Excellence criterion. If you claim TRL 4 but have paying customers, you are underplaying your maturity and might be applying to the wrong programme. Getting TRL right is the foundation of a well-targeted EU funding strategy.
TRL 1 — Basic principles observed. You have identified a scientific phenomenon or formulated a hypothesis that could lead to a technology application. At this stage, you are doing fundamental research: publishing papers, running theoretical models, and exploring physical or computational principles. No application has been defined yet.
TRL 2 — Technology concept formulated. You have moved from "this phenomenon exists" to "this phenomenon could solve a specific problem." You have defined a potential application and begun exploring how the underlying science could be engineered into a working technology. Feasibility studies, literature reviews, and initial computational modelling typically characterise TRL 2.
TRL 3 — Experimental proof of concept. You have demonstrated that the core concept works in a laboratory setting. This is the critical transition from science to engineering — you have built something (however crude) that validates the fundamental mechanism. Key evidence includes laboratory measurements, initial prototypes (even non-functional ones that demonstrate the principle), and peer-reviewed publications describing experimental results.
For EU funding purposes, TRL 1–3 is the domain of the EIC Pathfinder, which supports high-risk, visionary research. Check the current programme record for the available grant and call conditions. Pathfinder explicitly funds ideas that are too early and too uncertain for any other investor. The 2025 round funded 44 projects out of 2,087 applications — a 2.1% success rate — reflecting the programme's appetite for genuinely radical concepts. Horizon Europe Collaborative Research (Pillar II) also funds TRL 2–4 work through Research and Innovation Actions (RIAs), though these require multi-partner consortia from at least three EU countries.
TRL 4 — Technology validated in laboratory. Your technology has been tested as an integrated system in a laboratory environment. The difference from TRL 3 is integration: at TRL 3 you proved individual components work; at TRL 4 you have combined them into a functioning prototype and demonstrated that the integrated system performs as expected under controlled conditions. Evidence includes laboratory test reports, functional prototypes, and performance data against defined specifications.
TRL 5 — Technology validated in relevant environment. This is the first step outside the lab. "Relevant environment" means conditions that approximate real-world operating conditions — though not necessarily at full scale. For a biotech startup, this might mean testing in a bioreactor that mimics industrial conditions. For a hardware company, it could mean outdoor testing of a scaled-down prototype. For software, it means deployment in a testbed with realistic data volumes and user loads.
TRL 4–5 is the sweet spot for EIC Transition, which bridges Pathfinder research results and market-ready innovation with grants of up to EUR 2.5 million. Transition requires that you have outputs from a previous Pathfinder or ERC Proof of Concept project. The first EIC Transition Seals of Excellence were issued in February 2026 — 228 proposals received the Seal, meaning they scored above the quality threshold but could not be funded due to budget constraints.
Horizon Europe Innovation Actions (IAs) also fund TRL 4–6 work, typically in multi-partner consortia. IAs cover 70% of eligible costs for commercial entities (100% for non-profits) and focus on bringing research results closer to market through piloting, testing, and demonstration activities.
TRL 6 — Technology demonstrated in relevant environment. Your technology has been demonstrated as a prototype system in an environment that represents realistic operating conditions. The key distinction from TRL 5 is scale and fidelity: at TRL 6, the prototype is close to the planned operational system in terms of performance, reliability, and form factor. This is typically where you have pilot installations, beta versions with real users, or pre-production manufacturing runs.
TRL 7 — System prototype demonstrated in operational environment. The technology works in its actual operating environment at or near full scale. For a medical device, this means clinical trials. For an industrial system, this means deployment in a real factory or plant. For software, this means production deployment with paying customers (even early ones). TRL 7 is the final validation step before productisation — you know it works in the real world, now you need to engineer it for manufacturing, scale, and support.
TRL 6–7 is the primary entry range for the EIC Accelerator, which provides up to EUR 2.5 million in grant funding and up to EUR 10 million in equity investment. The 2026 Work Programme introduced significant changes: full proposals are now 20 pages (down from 50), the minimum equity component is EUR 1 million (up from EUR 500,000), and there are six bimonthly cut-off dates throughout the year.
Evaluators will scrutinise your TRL claim carefully. At TRL 6, they expect to see pilot data, user feedback, and performance benchmarks. At TRL 7, they expect evidence of real-world deployment: customer testimonials, site visit reports, or independent testing results. The evidence must be specific and verifiable — "we tested with 3 industrial partners" is credible; "we plan to test soon" is TRL 5 at best.
TRL 8 — System complete and qualified. Your technology has been proven to work in its final form under expected operating conditions. All manufacturing processes are established, quality assurance is in place, and regulatory approvals (if applicable) have been obtained or are in advanced stages. The difference from TRL 7 is completeness: at TRL 8, there are no remaining technical risks, only commercial and scaling challenges.
TRL 9 — Actual system proven in operational environment. The technology is fully deployed, commercially available, and has a track record of successful operation. This is the end state — a product on the market with paying customers and operational data demonstrating reliability and performance at scale.
For EU funding purposes, TRL 8–9 is typically beyond the scope of R&D grants. However, several instruments support scaling at this stage:
The EIC Accelerator's equity component (up to EUR 10 million from the EIC Fund) explicitly targets the gap between technology completion and market scale-up. Companies at TRL 8 are strong EIC Accelerator candidates because they can demonstrate a working product while making a credible case for why they need public investment to scale.
The EIC STEP Scale Up programme is a separate route for larger deep-tech scaling investments. Consult its current programme record for the ticket range, eligibility and call schedule. InvestEU provides guarantee-backed venture debt and growth financing through financial intermediaries. And the EU Innovation Fund (separate from Horizon Europe, funded by Emissions Trading System revenues) provides grants for first-of-a-kind commercial deployments in clean technology.
Evaluators do not take your TRL claim at face value. They look for evidence — and the type of evidence expected at each level is well defined in the European Commission's TRL guidance.
At TRL 1–2, evidence means peer-reviewed publications, theoretical models, and feasibility analyses. At TRL 3, you need laboratory test results and proof-of-concept data. At TRL 4–5, you need integrated system test reports, prototype performance data, and ideally independent verification. At TRL 6–7, you need pilot deployment data, user feedback, performance benchmarks against commercial specifications, and ideally letters from pilot sites or beta customers confirming real-world testing. At TRL 8–9, you need production specifications, regulatory certifications, customer contracts, and operational performance data.
A common mistake is conflating business progress with technology readiness. Having paying customers does not automatically mean TRL 9 if your product is still being manually configured for each deployment. Having a patent does not mean TRL 4 if you have never built a prototype. TRL measures the maturity of the technology itself, not the maturity of the business.
Another frequent error is presenting different TRL levels in different parts of the proposal. Your TRL claim in the technical section must be consistent with the evidence in your annexes, the development timeline in your work plan, and the budget allocation (if you are spending 70% of the budget on R&D, you are probably not at TRL 7).
The Horizon Europe 2026–2027 Work Programme uses a scoring system of 0–5 per evaluation criterion (Excellence, Impact, Implementation), with a minimum of 3 per criterion and a minimum of 10 total out of 15. Accurate TRL assessment directly affects your Excellence score — overstating or understating your readiness level undermines credibility on this critical criterion.
TRL is a 1–9 scale, used across Horizon Europe and the EIC, that measures how mature a technology is — from basic principles observed (TRL 1) to a system proven in commercial operation (TRL 9). EU programmes target specific TRL bands, so your level decides which funding you can apply for.
TRL 5/6 to 8. Your core technology must already be validated in a relevant environment (TRL 5 completed) before applying; the grant funds innovation activities at TRL 6–8 to bring it to market.
EIC Pathfinder funds early research at TRL 1–4. EIC Transition bridges TRL 3–6 (validating prior research results toward market). EIC Accelerator funds TRL 5–8 (scaling a market-ready innovation). Use the assessment above to see your exact matches.
They assess the TRL of your specific innovation (not your company) against evidence: lab data for TRL 3–4, performance in a relevant environment for TRL 5–6, and operational-environment demonstration for TRL 7+. Over-claiming your TRL is a common reason proposals fail.
The funding gap around TRL 4–7, where a technology is too mature for basic-research grants but too unproven for commercial investment. EIC Transition and the EIC Accelerator's blended finance are designed specifically to bridge it.
Yes. Evaluators look at the TRL of the specific innovation that the funding will advance. A system can integrate mature (TRL 8) and novel (TRL 4) components — what matters is the readiness of the part you're seeking funding to develop.
How the EU Funding & Tenders Portal works: finding a call, reading a topic page, the PIC, partner search, submission and the calls EU projects run for startups.
How Enisa participative loans work in 2026: 25,000 to 1.5 million euros, no guarantees, two years interest-only, and what Enisa checks before it lends.
Germany's Central Innovation Programme for SMEs (ZIM): who it funds, funding rates up to 60%, project types, and the 2026 application stop.
Every open and forthcoming Horizon Europe call by cluster, with the next deadlines, rebuilt from the EU Funding & Tenders Portal whenever the calls change.
Ask about your own project in Claude, ChatGPT or Grok. With EUACC connected, your AI places it on the TRL scale and answers with the readiness map: move the marker to compare funding routes, then open the evidence behind them.
Describe where your project really is. Your AI places it on the TRL scale and maps the EU routes that fit, using EUACC’s live programme records.
Autoplay · replays in 26s
Illustrated conversation. Programme and source records come from the live catalogue; budget inputs are examples. These interactive tools are also supplied by the MCP in supporting clients.
Programme facts come from the catalogue. A matching TRL range is a starting point, not an eligibility decision. Interactive display depends on your AI client.
Bring this into your AI ↗